Abbott Closes Sturgis, MI Plant
Selected formulas are part of a voluntary recall and the plant, which manufactures all of Abbott’s metabolic products, is closed.
Timeline of the shortages
11 entries, February to November 2022. The supplier statements that follow each of these are in supplier updates, which continue to April 2023.
Medical Community Mobilizes
Metabolic RDs & patient groups convene to address shortage
metabolicformula.org launched
By a coalition of organizations affected by the shortages.
Abbott’s Urgent Release Program initiated
Enabling access to metabolic products manufactured prior to the closing of the Sturgis plant.
Sturgis reopens
Sturgis closes
Due to flooding caused by rainstorms
Coram/CVS metabolic discontinuations
Reducing access to more than 50 metabolic products
Sturgis reopens again
Speciality and metabolic products are given priority in the reopening plan
Abbott restarts manufacture of metabolic products
Loose timelines provided for release, starting in September
Release Dates Shift
Abbott announces some metabolic products won’t be released until as late as January 2023
Release dates shift again
Release dates for more products shifted to November, December and January 2023